Interaction between bFGF and anti-angiogenic drug suradista: A possible induced-fit mechanism.

被引：0
|
作者：
Parola, AH
Hariharan, C
Cohen-Luria, R
Moreno, Z
Pines, E
Yayon, A
机构：
[1] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel
[2] Pharmacia & Upjohn Inc, Milan, Italy
[3] Weizmann Inst Sci, Dept Mol & Cellular Biol, IL-76100 Rehovot, Israel
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2000年 / 220卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
470-PHYS
引用
收藏
页码：U225 / U225
页数：1
相关论文
共 47 条
  • [41] Interaction between sodium tanshinone IIA sulfonate and the adriamycin semiquinone free radical: A possible mechanism for antagonizing adriamycin-induced cardiotoxity
    Zhou, GY
    Jiang, W
    Zhao, Y
    Ma, GE
    Li, SG
    Xin, WJ
    Zhao, BL
    RESEARCH ON CHEMICAL INTERMEDIATES, 2002, 28 (04) : 277 - 289
  • [42] Interaction between sodium tanshinone IIA sulfonate and the adriamycin semiquinone free radical: A possible mechanism for antagonizing adriamycin-induced cardiotoxity
    Guangyin Zhou
    Wen Jiang
    Yan Zhao
    Guang-En Ma
    Shengguang Li
    Wenjuan Xin
    Baolu Zhao
    Research on Chemical Intermediates, 2002, 28 : 277 - 289
  • [43] ELUCIDATION OF THE MECHANISM OF THERAPEUTIC PROTEIN-DRUG INTERACTION (TPDI) BETWEEN METHOTREXATE (MTX) AND AN ANTI-TNFα MONOCLONAL ANTIBODY (MAB), GOLIMUMAB.
    Wang, W.
    Leu, J.
    Zhou, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S94 - S95
  • [44] An apparent clinical pharmacokinetic drug–drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism
    Ka Wang
    Franziska Schaedeli Stark
    Tilman Schlothauer
    Angelika Lahr
    Valerie Cosson
    Jianguo Zhi
    Kai Habben
    Jean Tessier
    Eginhard Schick
    Roland F. Staack
    Oliver Krieter
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 661 - 671
  • [45] An apparent clinical pharmacokinetic drug-drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism
    Wang, Ka
    Stark, Franziska Schaedeli
    Schlothauer, Tilman
    Lahr, Angelika
    Cosson, Valerie
    Zhi, Jianguo
    Habben, Kai
    Tessier, Jean
    Schick, Eginhard
    Staack, Roland F.
    Krieter, Oliver
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (04) : 661 - 671
  • [46] HETEROCLITIC POLYCLONAL AND MONOCLONAL ANTI-GM(A) AND ANTI-GM(G) HUMAN RHEUMATOID FACTORS REACT WITH EPITOPES INDUCED IN GM(A-), GM(G-) IGG BY INTERACTION WITH ANTIGEN OR BY NONSPECIFIC AGGREGATION - A POSSIBLE MECHANISM FOR THE INVIVO GENERATION OF RHEUMATOID FACTORS
    WILLIAMS, RC
    MALONE, CC
    CASALI, P
    JOURNAL OF IMMUNOLOGY, 1992, 149 (05): : 1817 - 1824
  • [47] Interaction between the HIF-1α gene rs1957757 polymorphism and CpG island methylation in the promoter region is associated with the risk of anti-tuberculosis drug-induced liver injury in humans: A case-control study
    Chong, Yingzhi
    Zhu, Hanyu
    Ren, Qi
    Ma, Xinyi
    Feng, Fumin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (07) : 948 - 955
12345